VORANIGO (R) was approved by Health Canada in August 2024 for the treatment of Grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation in adults and pediatric patients aged ...
Lundin Gold Inc. (TSX: LUG) (Nasdaq Stockholm: LUG) (OTCQX: LUGDF) ("Lundin Gold" or the "Company") is pleased to announce that the Toronto Stock Exchange (the "TSX") has accepted the notice of Lundin ...
In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins ...
Silence in Japanese English as a Foreign Language (EFL) classroom is a culturally and socially mediated phenomenon that challenges Western pedagogical assumptions equating verbal participation with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results